A calipers-free intravitreal anti-VEGF injection technique
نویسندگان
چکیده
منابع مشابه
A calipers-free intravitreal anti-VEGF injection technique.
Dear Editor, Intravitreal injection of drugs such as anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids has shown encouraging results in the treatment of many ocular diseases. In developed countries, this type of injection is probably the most frequently performed vitreoretinal procedure. However, it has the potential for serious complications, such as endophthalmiti...
متن کاملIntravitreal injection technique
This article describes how to give an intravitreal injection of an anti-VEGF drug. At present, the majority of intravitreal injections are administered by doctors; however, experience in the UK has shown that trained nurses can give these injections as safely as ophthalmologists. The single most important thing to remember is that an intravitreal injection is an intraocular operation, and shoul...
متن کاملEndophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
The purpose of this review is to report and summarize previously reported studies and assess many of the individual steps of the intravitreal injection procedure's possible effect on the prevention of endophthalmitis. The pooled endophthalmitis rate from 20 large retrospective case series of anti-VEGF injections was 144/510,396 (0.028%; 1/3,544). Injections may be performed in an office-based l...
متن کاملComparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
The aim of this study was to compare the incidence of systemic adverse events in patients treated with intravitreal injections of bevacizumab or ranibizumab, and to evaluate whether compared to ranibizumab administration, bevacizumab constitutes a higher risk for systemic adverse events. A retrospective review was conducted for 916 consecutive patients treated with at least 1 intravitreal injec...
متن کاملObservation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
PURPOSE Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth factor (VEGF) receptor-IgG fusion protein, has been developed as a new drug for ocular neovascularization and macular edema. The present study aims to clarify the changes in conbercept levels, VEGF, and intraocular pressure (IOP) after the intravitreal injection of conbercept into diabetic mouse eyes. METHODS...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arquivos Brasileiros de Oftalmologia
سال: 2015
ISSN: 0004-2749
DOI: 10.5935/0004-2749.20150034